电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

SensoLyte® Rh110 Factor Xa Assay Kit

FRET Fluorometric
产品编号 ABIN1882458
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for SensoLyte® Rh110 Factor Xa Assay Kit (ABIN1882458)

抗原

See all Factor Xa (FXa) 试剂盒
Factor Xa (FXa) (Activated Coagulation Factor X (FXa))

检测方法

Fluorometric

应用范围

Fluorescence Resonance Energy Transfer Microscopy (FRET)
  • 产品特性

    The SensoLyte® Rh110 Factor Xa Assay Kit provides a convenient assay for screening of FXa inhibitors or continuous assay of enzyme activity using a fluorogenic substrate. Upon FXa protease cleavage, this substrate generates the Rh110 (rhodamine 110) fluorophore which has a bright green fluorescence that can be detected at excitation/emission=490 nm/520 nm. The longer-wavelength spectra and higher extinction coefficient of the Rh110 provide greater sensitivity and less interference from other reaction components.
  • 说明

    FRET-based Assay Kit

    限制

    仅限研究用
  • 注意事项

    Protect Components A and B from light and moisture.

    储存条件

    -80 °C

    储存方法

    Store all kit components at -20 °C, except for Component C. Store Component C at -80 °C. Component D can be stored at room temperature for convenience
  • 抗原

    Factor Xa (FXa) (Activated Coagulation Factor X (FXa))

    别名

    Factor Xa

    背景

    Factor Xa (FXa) is a serine endopeptidase composed of two disulfide-linked subunits. FXa leads to blood clot formation by converting prothrombin to thrombin through the prothrombinase complex. FXa is generated from zymogen Factor X via the intrinsic and extrinsic pathways and is the rate-limiting step in the propagation of thrombin generation. In the presence of Ca2+ ions, FXa forms prothrombinase with factor Va on the phospholipid membrane of the activated platelets. FXa has emerged as an attractive target for drug discovery for thromboembolic diseases.
You are here: